Arca Biopharma

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Arca Biopharma ( ABIO) is a biopharmaceutical company whose principal focus is developing genetically-targeted therapies for heart failure and other cardiovascular diseases. This stock is trading up 7.4 % to $0.58 in recent trading.

Today's Range: $0.54-$0.58

52-Week Range: $0.37-$2.45

Volume: 58,000

Three-Month Average Volume: 80,881

From a technical perspective, ABIO is ripping to the upside here with decent volume, and the stock is quickly moving within range of triggering a major breakout trade. That trade will trigger once ABIO takes out some near-term overhead resistance at 61 cents with high volume.

Traders should now look for long-biased trades once ABIO sustains a move or close over 61 cents with volume that's near or above 80,881 shares. If we get that action soon, then ABIO could potentially skyrocket back towards its next major overhead resistance level at 83 cents, or possibly even its 200-day moving average of 90 cents. Traders should use the 50-day moving average of 49 cents to key off of for major near-term support for ABIO.

To see more stocks under-$10 that are making notable moves higher today, check out the Stocks Under-$10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Winderemere, Fla.


Follow Stockpickr on Twitter and become a fan on Facebook.
At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Windermere, Fla., is an independent trader who focuses on stocks, options, futures, commodities and currencies. He is also an outside contributor to and maintains the website, which he sold to Blue Wave Advisors in 2008. Roberto studied International Business at The Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany.

If you liked this article you might like

OCZ's $35 Million Sale to Toshiba Leaves Zero for Shareholders

OCZ Technology's Bears Win; Toshiba Buys Remains

3 Tech Stocks Under $10 to Watch

2 Tech Stocks Gearing Up to Break Out

The Deal: OCZ's Going Nowhere Fast